NDC 63323-145

Floxuridine

Floxuridine

Floxuridine is a Intra-arterial Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Floxuridine.

• Product ID: 63323-145_9b00ef55-2f80-a983-e053-2995a90a45ab
• NDC: 63323-145
• Product Type: Human Prescription Drug
• Proprietary Name: Floxuridine
• Generic Name: Floxuridine
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRA-ARTERIAL
• Marketing Start Date: 2001-03-15
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075837
• Labeler Name: Fresenius Kabi USA, LLC
• Substance Name: FLOXURIDINE
• Active Ingredient Strength: 500 mg/5mL
• Pharm Classes: Antimetabolite [EPC],Deoxyuridine [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 63323-145-07

1 VIAL in 1 CARTON (63323-145-07) > 5 mL in 1 VIAL

• Marketing Start Date: 2001-03-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63323-145-07 [63323014507]

Floxuridine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075837
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2001-03-15

Drug Details

Active Ingredients

Ingredient	Strength
FLOXURIDINE	500 mg/5mL

OpenFDA Data

• SPL SET ID: c8edabc1-67cd-421b-a147-7c1f19f05b8e
• Manufacturer:
  • Fresenius Kabi USA, LLC
• UNII:
  • 039LU44I5M
• RxNorm Concept Unique ID - RxCUI:
  • 310351

Pharmacological Class

• Antimetabolite [EPC]
• Deoxyuridine [CS]

NDC Crossover Matching brand name "Floxuridine" or generic name "Floxuridine"

NDC	Brand Name	Generic Name
0143-9270	Floxuridine	Floxuridine
63323-145	Floxuridine	FLOXURIDINE
81643-9270	Floxuridine	Floxuridine